Eucomed releases guidance on implementing a risk-based UDI system
This article was originally published in RAJ Devices
European medical technology industry association Eucomed has issued guidance on how a unique device identification system could be implemented in a practical way by using a risk-based approach1,2.
You may also be interested in...
Now that the European Medicines Agency has finalized its formal safety review procedure into Xeljanz, Pfizer is telling health care professionals what precautions they must take when prescribing the drug.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.